月K · MACD · 年ROE Monthly Trend · 美元
MACD(12,26,9)
MACD · 前复权口径
年ROE（每份年报一根整柱，柱宽 = 生效期：报告期 + 4 个月起）
加载中…
获利能力 Profitability (单位：美元)
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 净资产收益率（ROE） | 24.46% | 23.96% | -20.31% | 53.25% | 46.20% | 33.49% | 28.89% | 28.92% | 14.49% | 16.09% | 19.16% | -1.59% | 30.18% | 133.78% | 150.18% | 76.35% | 63.63% | 48.92% | 84.57% | 101.16% | 51.74% | 47.97% |
| 总资产收益率（ROA） | 12.13% | 11.02% | -7.09% | 15.76% | 16.35% | 12.92% | 11.89% | 13.29% | 6.58% | 6.77% | 7.05% | -0.45% | 7.36% | 21.17% | 13.28% | 11.44% | 12.62% | 8.19% | 13.45% | 18.35% | 8.34% | 10.18% |
| 毛利率 | 77.40% | 77.20% | 78.52% | 80.55% | 81.08% | 79.13% | 78.78% | 78.76% | 74.85% | 74.76% | 73.09% | 77.73% | 78.22% | 78.85% | 77.66% | 74.18% | 76.77% | 79.25% | 81.31% | 83.04% | 83.48% | 84.00% |
| 净利率 | 16.97% | 15.85% | -10.17% | 19.82% | 21.97% | 17.90% | 18.09% | 20.27% | 12.19% | 12.07% | 12.90% | -1.02% | 15.04% | 37.27% | 25.24% | 19.71% | 21.88% | 15.36% | 23.51% | 31.67% | 29.77% | 33.88% |
| 每股收益（EPS） | 2.45 | 2.71 | -1.89 | 3.94 | 4.58 | 3.90 | 3.67 | 4.33 | 2.23 | 2.27 | 2.59 | -0.19 | 3.14 | 8.93 | 6.82 | 6.15 | 6.93 | 5.82 | 11.76 | 23.00 | 9.37 | 16.22 |
财务结构 Financial Structure
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金占总资产比率 | 14.16% | 12.02% | 18.82% | 16.25% | 19.33% | 17.60% | 11.68% | 10.87% | 10.66% | 10.31% | 11.81% | 14.53% | 16.67% | 5.95% | 7.84% | 7.82% | 4.18% | 4.40% | 4.15% | 6.46% | 3.35% | 6.29% |
| 负债占总资产比率 | 49.99% | 48.99% | 76.94% | 65.31% | 59.96% | 59.79% | 57.05% | 49.95% | 57.62% | 58.98% | 63.72% | 74.06% | 75.15% | 93.13% | 87.51% | 81.24% | 78.23% | 83.03% | 81.87% | 76.41% | 81.82% | 76.19% |
经营能力 Operating Capability
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 应收账款周转率(次) | 6.83 | 6.97 | 7.33 | 6.53 | 6.60 | 6.75 | 6.77 | 6.73 | 6.06 | 5.68 | 5.27 | 4.39 | 4.68 | 4.91 | 4.18 | 4.24 | 4.14 | 3.75 | 4.09 | 3.67 | 2.00 | 2.13 |
| 平均收现日数 | 53 天 | 52 天 | 50 天 | 56 天 | 55 天 | 54 天 | 54 天 | 54 天 | 60 天 | 64 天 | 69 天 | 83 天 | 78 天 | 74 天 | 87 天 | 86 天 | 88 天 | 97 天 | 89 天 | 99 天 | 183 天 | 171 天 |
| 固定资产周转率(次) | - | 0.4602 | 0.4234 | 0.3754 | 0.3441 | 0.3195 | 0.3433 | 0.3451 | 0.4060 | 0.4035 | 0.3889 | 0.4419 | 0.3720 | 0.3527 | 0.3538 | 0.3173 | 0.3554 | 0.3784 | 0.3797 | 0.3786 | 0.7258 | 0.6847 |
| 总资产周转率 | 71.47% | 69.56% | 69.74% | 79.52% | 74.44% | 72.15% | 65.71% | 65.57% | 54.03% | 56.11% | 54.69% | 44.40% | 48.95% | 56.81% | 52.62% | 58.02% | 57.67% | 53.31% | 57.22% | 57.95% | 28.03% | 30.06% |
现金流量 Cash Flow (单位：亿美元)
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金及现金等价物 | 31.09 | 32.20 | 54.97 | 44.63 | 59.93 | 59.22 | 40.19 | 38.30 | 38.72 | 36.66 | 45.82 | 65.36 | 73.21 | 23.38 | 36.57 | 38.18 | 20.67 | 28.19 | 32.68 | 72.68 | 33.76 | 89.50 |
| 净利润 | 26.63 | 29.53 | -20.72 | 43.29 | 50.70 | 43.48 | 40.89 | 46.85 | 23.90 | 24.08 | 27.38 | -2.04 | 32.32 | 83.18 | 61.94 | 55.82 | 62.45 | 52.40 | 105.90 | 206.40 | 84.20 | 144.91 |
| 经营活动现金流量 | 39.76 | 51.54 | 72.96 | 43.36 | 68.57 | 72.34 | 53.05 | 57.35 | 44.58 | 29.65 | 48.51 | 56.16 | 55.24 | 48.37 | 65.00 | 73.66 | 75.86 | 42.40 | 88.18 | 168.13 | 47.53 | 160.23 |
| 投资活动现金流量 | 6.08 | -43.28 | -72.69 | 1.43 | -31.60 | -48.24 | -28.33 | -20.73 | -39.09 | 0.27 | -31.39 | -37.84 | 19.06 | -80.83 | -22.59 | -28.68 | -37.63 | -71.53 | -93.02 | -109.72 | -51.87 | -193.12 |
| 筹资活动现金流量 | -45.79 | -8.45 | 23.46 | -55.34 | -20.22 | -23.70 | -44.20 | -38.29 | -1.66 | -31.11 | -5.60 | 1.43 | -59.05 | -23.24 | -31.37 | -41.31 | -54.07 | 34.96 | 12.30 | -22.13 | 1.35 | 49.56 |
| 净现金流量 | 1.03 | 1.11 | 22.76 | -10.34 | 15.30 | -0.71 | -19.04 | -1.89 | 0.41 | -2.05 | 9.16 | 19.54 | 14.62 | -56.61 | 13.20 | 1.61 | -17.52 | 7.52 | 4.49 | 40.00 | 1.08 | 16.82 |
右侧两列为报告期累计口径同比（左：去年同期同一期次，右：最近一期季报，年报期次已在左侧列展示）；周转率类指标为报告期累计值，未做年化。
医疗保健
- 近五年ROE对比
1
100.00%
PACS Group Inc
次新股
PACS
2
100.00%
ImmunityBio Inc
亏损年份
IBRX
3
100.00%
安进
AMGN
4
100.00%
奥洛兹美医疗
HALO
5
100.00%
Puma Biotechnology Inc
亏损年份
PBYI
6
100.00%
沃特世
WAT
7
100.00%
Picard Medical Inc
数据<5年
亏损年份
次新股
PMI
8
84.37%
IDEXX实验室
IDXX
9
79.94%
泰尼特保健
THC
10
74.93%
礼来
LLY
11
74.56%
诺和诺德
NVO
12
62.37%
BridgeBio Pharma Inc
亏损年份
BBIO
13
52.47%
硕腾
ZTS
14
50.94%
NRC Health
NRC
15
49.16%
Medpace Holdings Inc
MEDP
16
48.89%
葛兰素史克
GSK
17
32.44%
Harmony Biosciences Holdings In
HRMY
18
32.16%
Innoviva Inc
INVA
19
31.55%
强生
JNJ
20
30.84%
默沙东
MRK
21
30.27%
Chemed Corp
CHE
22
29.98%
InMode Ltd
INMD
23
28.48%
西佳科技
SIGA
24
27.65%
爱德华兹生命科学
EW
25
26.99%
诺华制药
NVS
26
25.87%
Catalyst Pharmaceuticals Inc
CPRX
27
24.94%
Molina Healthcare Inc
MOH
28
24.45%
再生元制药
REGN
29
24.38%
吉利德科学
GILD
30
24.35%
瑞思迈
RMD